The major players in the community oncology services market are Community Care Physicians PC, Nebraska Cancer Specialists, US Oncology, Inc. (McKesson Corporation), Tufts Medical Center, Doctors Medical Center, Oncology Specialists, S.
New York, September 27, 2021 (GLOBE NEWSWIRE) – Reportlinker.com announces the publication of the report “Community Oncology Services Global Market Report 2021: COVID-19 Growth And Change To 2030” – https://www.reportlinker.com/p06151621/?utm_source=GNW
C., and Baptist Cancer Center.
The global community oncology services market is expected to grow from $ 70.98 billion in 2020 to $ 70.78 billion in 2021 at a compound annual growth rate (CAGR) of -0.3%. The slow decline is attributed to restrictive COVID-19 containment measures involving social distancing, remote working and the shutdown of business activities which have resulted in operational challenges. The market is expected to reach $ 69.97 billion in 2025 at a CAGR of -0.2%.
The community oncology services market includes sales of community oncology services by entities (organizations, independent traders and partnerships) of health care practitioners who practice community oncology as a private company owned by a physician. not part of a hospital or a university or medical educational institution. The community of oncology practice may be a single oncologist, with an office and support staff consisting of auxiliary physicians, nurses, pharmacists or pharmacy technicians and other staff.
Only goods and services traded between entities or sold to final consumers are included.
The Community Oncology Services market covered in this report is segmented by Type into Small Community Oncology Clinics, Mid-Size Community Oncology Clinics, Large Community Oncology Clinics; type of cancer in breast cancer, lung cancer, kidney cancer, liver cancer, ovarian cancer, prostate cancer, skin cancer, pancreatic cancer, blood cancer, colorectal cancer, others.
The regions covered in this report are Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East & Africa.
The coronavirus outbreak is likely to act as a major drag on the growth of the community oncology services market during the forecast period. The World Health Organization (WHO) declared the COVID-19 outbreak a pandemic on March 11, 2020.
The coronavirus has created a significant risk of death for cancer patients around the world. COVID-19 is expected to have a long-term impact on oncology practices.
Healthcare practices have seen a 55% drop in revenue and a 60% drop in patient volume since the start of the COVID pandemic, according to a survey conducted by the Medical Group Management Association in April 2020 -19. a survey of 51 U.S. oncologists conducted by MJH Life Sciences in May 2020, 73% of oncologists limited their surgeries to urgent cases, 53% changed dosing schedules to reduce inpatient visits, and 71% canceled visits routine of patients. .
As a result, the coronavirus outbreak caused a rapid decline in overall in-person oncology services, impacting the market for community-based oncology services.
In May 2019, Amgen announced its decision to collaborate with community-based oncology service providers such as US Oncology Research and TRIO-US to improve community centers’ access to innovative clinical research in oncology. This collaboration is expected to allow Amgen to significantly expand its clinical research footprint to more than 200 patient care sites across the United States and help community centers reach over 900,000 new patients each year with drugs. experimental.
Lower cost care in community oncology centers is expected to stimulate demand for the community oncology service market. Cancer care services are seen as cost effective in community cancer centers compared to hospitals.
According to the Community Oncology Alliance report published in October 2018, the cost of cancer care per patient per month for various tumors in community clinics (CC) was around $ 12,000 while the cost of cancer care cancer in hospital oncology (CS) clinics was approximately $ 20,000. In addition, the cost per patient per month for chemotherapy treatment in a community setting was almost $ 5,000, compared to about $ 8,500 in inpatient clinics.
Hence, the low cost of community oncology facilities or community oncology centers is expected to drive the demand for the community oncology services market during the forecast years.
Large companies are making various acquisitions and research collaborations in the community oncology services market to expand their services and offerings, which has been gaining popularity in recent years. According to a report released by the Community Oncology Alliance in April 2020, the rate of hospital-acquired community oncology practices increased by 9.7% in 2018 and 2020. For example, in August 2020, The Community Cancer Center, a clinic company engaged in providing community cancer care, was acquired by Carle Health. Carle Health is a US-based hospital and healthcare company with more than 9,500 employees in its five hospitals and associated healthcare operations. Additionally, in May 2019, Amgen Inc., a US-based biopharmaceutical company, announced new research collaborations with community oncology networks. Amgen Inc. also launched Amgen Community Oncology Research Collaborators (ACORC), a new initiative to improve access to innovative clinical research in oncology for community centers.
The countries covered in the market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, United Kingdom and United States.
Read the full report: https://www.reportlinker.com/p06151621/?utm_source=GNW
On Report link
ReportLinker is an award winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
CONTACT: Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001